Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401270 · ClinicalTrials.gov registry record · NA
Prize Contingency Management for Cocaine-Dependent Methadone Patients
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT01401270 is a NA study that has completed, run by UConn Health. The registered enrollment target is 280 participants.
The verdict
NCT01401270, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
The investigators will randomize 300 cocaine-dependent methadone patients to 1 of 6 conditions: (a) a control group, (b) a contingency management condition that arranges a 100% probability of winning a prize with each draw and has 3 prize categories, (c) a contingency management condition that arranges a 31% probability of winning and has 3 prize categories, (d) a contingency management condition that arranges a 100% probability of winning and has 7 prize categories, (e) a contingency management condition that arranges a 31% probability of winning and has 7 prize categories, or (f) usual prize contingency management with a 50% probability of winning from 3 prize categories. Magnitudes of reinforcement will be identical across conditions, but lower overall probability conditions arrange for greater chances of winning larger magnitude prizes. The investigators expect that the new contingency management conditions will reduce cocaine use relative to the control condition, that 31% probability conditions will decrease drug use relative to 100% conditions, and that 7-prize category conditions will reduce drug use compared to 3-prize category conditions. In addition, the 31%/7-category condition is expected to be most efficacious. Results will be instrumental for further developing prize contingency management to improve outcomes of cocaine-dependent methadone patients.
Interventions
- BEHAVIORAL prize contingency management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01401270
The ClinicalTrials.gov registry entry for NCT01401270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which prize contingency management is the first listed.
NCT01401270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01401270 about?
NCT01401270 is a clinical study titled "Prize Contingency Management for Cocaine-Dependent Methadone Patients". The investigators will randomize 300 cocaine-dependent methadone patients to 1 of 6 conditions: (a) a control group, (b) a contingency management condition that arranges a 100% probability of winning a prize with each draw and has 3 prize categories, (c) a contingency management condition that arran...
What is the current status of trial NCT01401270?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2011-11. Estimated completion is 2018-05.
What interventions are being tested in trial NCT01401270?
The interventions under investigation include: prize contingency management (BEHAVIORAL).
Who is sponsoring clinical trial NCT01401270?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.